Testing effectiveness (Phase 2)WithdrawnNCT01320267What this trial is testingSingle Port Laparoscopic ColectomyWho this might be right forColon Cancer University of British Columbia
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)UnknownNCT00513266What this trial is testingCombination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryWho this might be right forColorectal CancerMetastatic Cancer Centre Hospitalier Universitaire Vaudois 35
Early research (Phase 1)Looking for participantsNCT05611034What this trial is testingIn Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to LungWho this might be right forLung MetastasesColorectal Cancer MetastaticColorectal Cancer University Health Network, Toronto 10
Testing effectiveness (Phase 2)UnknownNCT02466906What this trial is testingRhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon CancerWho this might be right forColon Cancer The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 60
Large-scale testing (Phase 3)UnknownNCT04552093What this trial is testingHepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)Who this might be right forColorectal Neoplasms The Netherlands Cancer Institute 31
Not applicableStudy completedNCT04926376What this trial is testingSafety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)Who this might be right forHepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer ABK Biomedical 8
Not applicableEnded earlyNCT02866344What this trial is testingResection Versus Microwave Ablation for Resectable Colorectal Cancer Liver MetastasesWho this might be right forColorectal NeoplasmsNeoplasm MetastasisHepatic Neoplasms Wake Forest University Health Sciences 1
Large-scale testing (Phase 3)Ended earlyNCT01842971What this trial is testingALPPS (Liver Partition and Portal Vein Ligation) for Two-stage Hepatectomy for Colorectal Liver MetastasisWho this might be right forColorectal Cancer Centre Hospitalier Universitaire, Amiens 3
Large-scale testing (Phase 3)UnknownNCT05948072What this trial is testingCetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLMWho this might be right forColorectal CancerLiver Metastases Fudan University 250
Testing effectiveness (Phase 2)UnknownNCT05371197What this trial is testingEnvafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal CancerWho this might be right forColorectal CancerMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)+1 more Third Affiliated Hospital, Sun Yat-Sen University 26
Large-scale testing (Phase 3)UnknownNCT02350166What this trial is testingShort-term Effects of LASI Surgery Versus Conventional Laparotomy for Colorectal Liver MetastasisWho this might be right forColorectal Cancer West China Hospital 40
Large-scale testing (Phase 3)UnknownNCT01035385What this trial is testingCompare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)Who this might be right forColorectal CancerLiver Metastasis Guangdong Provincial People's Hospital 340
Not applicableStudy completedNCT01343901What this trial is testingAn Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver MetastasesWho this might be right forColorectal Cancer Hoffmann-La Roche 210
Early research (Phase 1)Study completedNCT00059930What this trial is testingAdjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Memorial Sloan Kettering Cancer Center 38
Large-scale testing (Phase 3)UnknownNCT00630045What this trial is testingPhase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisWho this might be right forColorectal CancerResectable Liver Metastasis Peking University People's Hospital 392
Testing effectiveness (Phase 2)UnknownNCT00438737What this trial is testingCetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer European Organisation for Research and Treatment of Cancer - EORTC 100
Testing effectiveness (Phase 2)UnknownNCT00594529What this trial is testingFeasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal CancersWho this might be right forColorectal CancerLiver Metastasis Kyoto University 27
Large-scale testing (Phase 3)Looking for participantsNCT06280495What this trial is testingNeoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC PatientsWho this might be right forColorectal CancerLiver Metastases Sun Yat-sen University 156
Early research (Phase 1)Study completedNCT02754856What this trial is testingTremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by SurgeryWho this might be right forMetastatic Carcinoma in the LiverResectable MassStage IV Colorectal Cancer AJCC v7+2 more M.D. Anderson Cancer Center 24